Pharmacological Features of 18β-Glycyrrhetinic Acid: A Pentacyclic Triterpenoid of Therapeutic Potential

Overview

Journal Plants (Basel)

Date 2023 Mar 11

PMID 36903944

Authors

Pottathil Shinu

Girdhari Lal Gupta

Manu Sharma

Shahzad Khan

Manoj Goyal

Anroop B Nair

Manish Kumar

Wafaa E Soliman

Aminur Rahman

Mahesh Attimarad

Katharigatta N Venugopala

Abdullah Abdulhamid Ahmed Altaweel

Affiliations

Soon will be listed here.

Abstract

L. (belonging to the family Leguminosae), commonly known as Licorice, is a popular medicinal plant that has been used in traditional medicine worldwide for its ethnopharmacological efficacy in treating several ailments. Natural herbal substances with strong biological activity have recently received much attention. The main metabolite of glycyrrhizic acid is 18β-glycyrrhetinic acid (18βGA), a pentacyclic triterpene. A major active plant component derived from licorice root, 18βGA has sparked a lot of attention due to its pharmacological properties. The current review thoroughly examines the literature on 18βGA, a major active plant component obtained from L. The current work provides insight into the pharmacological activities of 18βGA and the potential mechanisms of action involved. The plant contains a variety of phytoconstituents such as 18βGA, which has a variety of biological effects including antiasthmatic, hepatoprotective, anticancer, nephroprotective, antidiabetic, antileishmanial, antiviral, antibacterial, antipsoriasis, antiosteoporosis, antiepileptic, antiarrhythmic, and anti-inflammatory, and is also useful in the management of pulmonary arterial hypertension, antipsychotic-induced hyperprolactinemia, and cerebral ischemia. This review examines research on the pharmacological characteristics of 18βGA throughout recent decades to demonstrate its therapeutic potential and any gaps that may exist, presenting possibilities for future drug research and development.

Citing Articles

Potential mechanism of traditional Chinese medicine intervention in gastric cancer: targeted regulation of autophagy.

Sun S, Yu W, Zhang G, Li X, Song L, Lv Y Front Pharmacol. 2025; 16:1548672.

PMID: 40066330 PMC: 11891941. DOI: 10.3389/fphar.2025.1548672.

Protective effects of 18β-glycyrrhetinic acid on -induced vascular inflammatory injury in mice.

Lu Q, Wang L, Jiang X, Han W, Guo P, Liu Y Front Vet Sci. 2025; 11():1515977.

PMID: 39850582 PMC: 11754287. DOI: 10.3389/fvets.2024.1515977.

Design and synthesis of glycyrrhetinic acid glycosides against acute lung injury and pulmonary fibrosis.

Li W, Liu J, Wu T, Qiang X, Peng Y, Zhao Q Mol Divers. 2024; .

PMID: 39621243 DOI: 10.1007/s11030-024-11058-6.

Genomic and transcriptomics analysis reveal putative secreted proteins expressed of during 18β-glycyrrhetinic acid treatment.

Wu Z, Zhang Y, Wang L, Mei M, Qiu Y, Liu Y Front Vet Sci. 2024; 11:1495924.

PMID: 39575438 PMC: 11578946. DOI: 10.3389/fvets.2024.1495924.

PVA-Stabilized and Coassembled Nano/Microparticles with High Payload of Dual Phytochemicals for Enhanced Antibacterial and Targeting Effect.

Yang H, Yang Y, Wang J, Dong Z, Wang J, Ma Y ACS Omega. 2024; 9(40):41990-42001.

PMID: 39398137 PMC: 11465548. DOI: 10.1021/acsomega.4c06925.

References

Wang X, Zhou Q, Lu Y, Zhang H, Huang S, Su S . Glycyrrhetinic acid potently suppresses breast cancer invasion and metastasis by impairing the p38 MAPK-AP1 signaling axis. Expert Opin Ther Targets. 2015; 19(5):577-87. DOI: 10.1517/14728222.2015.1012156. View

He R, Xu Y, Peng J, Ma T, Li J, Gong M . The effects of 18β-glycyrrhetinic acid and glycyrrhizin on intestinal absorption of paeoniflorin using the everted rat gut sac model. J Nat Med. 2016; 71(1):198-207. DOI: 10.1007/s11418-016-1049-2. View

Long D, Mead J, Hendricks J, Hardy M, Voyich J . 18β-Glycyrrhetinic acid inhibits methicillin-resistant Staphylococcus aureus survival and attenuates virulence gene expression. Antimicrob Agents Chemother. 2012; 57(1):241-7. PMC: 3535912. DOI: 10.1128/AAC.01023-12. View

Filippi M, Bar-Or A, Piehl F, Preziosa P, Solari A, Vukusic S . Multiple sclerosis. Nat Rev Dis Primers. 2018; 4(1):43. DOI: 10.1038/s41572-018-0041-4. View

Yang G, Wang L, Yu X, Huang Y, Qu C, Zhang Z . Protective Effect of 18-Glycyrrhetinic Acid against Triptolide-Induced Hepatotoxicity in Rats. Evid Based Complement Alternat Med. 2017; 2017:3470320. PMC: 5440796. DOI: 10.1155/2017/3470320. View

Kalaiarasi P, Kaviarasan K, Pugalendi K . Hypolipidemic activity of 18beta-glycyrrhetinic acid on streptozotocin-induced diabetic rats. Eur J Pharmacol. 2009; 612(1-3):93-7. DOI: 10.1016/j.ejphar.2009.04.003. View

Sun J, Liu H, Lv C, Qin J, Wu Y . Modification, Antitumor Activity, and Targeted PPARγ Study of 18β-Glycyrrhetinic Acid, an Important Active Ingredient of Licorice. J Agric Food Chem. 2019; 67(34):9643-9651. DOI: 10.1021/acs.jafc.9b03442. View

Kalaiarasi P, Pugalendi K . Antihyperglycemic effect of 18 beta-glycyrrhetinic acid, aglycone of glycyrrhizin, on streptozotocin-diabetic rats. Eur J Pharmacol. 2009; 606(1-3):269-73. DOI: 10.1016/j.ejphar.2008.12.057. View

Ma T, Huang C, Meng X, Li X, Zhang Y, Ji S . A potential adjuvant chemotherapeutics, 18β-glycyrrhetinic acid, inhibits renal tubular epithelial cells apoptosis via enhancing BMP-7 epigenetically through targeting HDAC2. Sci Rep. 2016; 6:25396. PMC: 4857087. DOI: 10.1038/srep25396. View

10.

Mahmoud A, Hussein O, Hozayen W, Abd El-Twab S . Methotrexate hepatotoxicity is associated with oxidative stress, and down-regulation of PPARγ and Nrf2: Protective effect of 18β-Glycyrrhetinic acid. Chem Biol Interact. 2017; 270:59-72. DOI: 10.1016/j.cbi.2017.04.009. View

11.

Wu S, Lu H, Wang W, Song L, Liu M, Cao Y . Prevention of D-GalN/LPS-induced ALI by 18β-glycyrrhetinic acid through PXR-mediated inhibition of autophagy degradation. Cell Death Dis. 2021; 12(5):480. PMC: 8119493. DOI: 10.1038/s41419-021-03768-8. View

12.

Zhang M, Chang Z, Zhang P, Jing Z, Yan L, Feng J . Protective effects of 18β-glycyrrhetinic acid on pulmonary arterial hypertension via regulation of Rho A/Rho kinsase pathway. Chem Biol Interact. 2019; 311:108749. DOI: 10.1016/j.cbi.2019.108749. View

13.

Xu B, Wu G, Zhang X, Yan M, Zhao R, Xue N . An Overview of Structurally Modified Glycyrrhetinic Acid Derivatives as Antitumor Agents. Molecules. 2017; 22(6). PMC: 6152714. DOI: 10.3390/molecules22060924. View

14.

Mun S, Park P, Park-Min K . The M-CSF receptor in osteoclasts and beyond. Exp Mol Med. 2020; 52(8):1239-1254. PMC: 8080670. DOI: 10.1038/s12276-020-0484-z. View

15.

Caglayan C, Kandemir F, Ayna A, Gur C, Kucukler S, Darendelioglu E . Neuroprotective effects of 18β-glycyrrhetinic acid against bisphenol A-induced neurotoxicity in rats: involvement of neuronal apoptosis, endoplasmic reticulum stress and JAK1/STAT1 signaling pathway. Metab Brain Dis. 2022; 37(6):1931-1940. DOI: 10.1007/s11011-022-01027-z. View

16.

Namik Oztanir M, Ciftci O, Cetin A, Durak M, Basak N, Akyuva Y . The beneficial effects of 18β-glycyrrhetinic acid following oxidative and neuronal damage in brain tissue caused by global cerebral ischemia/reperfusion in a C57BL/J6 mouse model. Neurol Sci. 2014; 35(8):1221-8. DOI: 10.1007/s10072-014-1685-9. View

17.

Zheng Y, Ley S, Hu F . Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol. 2017; 14(2):88-98. DOI: 10.1038/nrendo.2017.151. View

18.

Gupta P, Das P, Ukil A . Antileishmanial effect of 18β-glycyrrhetinic acid is mediated by Toll-like receptor-dependent canonical and noncanonical p38 activation. Antimicrob Agents Chemother. 2015; 59(5):2531-9. PMC: 4394830. DOI: 10.1128/AAC.03997-14. View

19.

Kim S, Hong J, Lee J, Lee Y . 18β-Glycyrrhetinic acid, the major bioactive component of Glycyrrhizae Radix, attenuates airway inflammation by modulating Th2 cytokines, GATA-3, STAT6, and Foxp3 transcription factors in an asthmatic mouse model. Environ Toxicol Pharmacol. 2017; 52:99-113. DOI: 10.1016/j.etap.2017.03.011. View

20.

Shi X, Yu L, Zhang Y, Liu Z, Zhang H, Zhang Y . Glycyrrhetinic acid alleviates hepatic inflammation injury in viral hepatitis disease via a HMGB1-TLR4 signaling pathway. Int Immunopharmacol. 2020; 84:106578. PMC: 7205693. DOI: 10.1016/j.intimp.2020.106578. View